Shares of Eli Lilly (LLY) and other pharmaceutical companies dropped significantly on Friday. The selloff was triggered by the announcement that the Department of Health and Human Services announced that the company’s Tradjenta was selected for Medicare drug price negotiations. Tradjenta is an oral diabetes medicine that helps control blood sugar levels. The Department of […]
The post Eli Lilly Faces ‘Death Cross’ Selloff: This is the Stock's Next Target Price… appeared first on Money Morning – We Make Investing Profitable.
